NEW YORK (GenomeWeb News) – Consumer genetic testing and ancestry firm Pathway Genomics said today that it has licensed genetic disease information developed by Harvard Medical School through an agreement with StayWell Consumer Health Publishing.
The content covered under the agreement was developed by HMS and Harvard Health Publications. Pathway Genomics will use it to offer its Genetic Health Reports, which provide its customers with information about genetic diseases and medical information such as symptoms, diagnosis, duration, prevention, and treatment options.
"When customers review their Genetic Health Reports they want to easily access detailed information – from a trusted source – about health conditions reported with their genetic results," Pathway Genomics Chief Medical Officer Michael Nova said in a statement.
While genetic testing can tell if individuals have certain genetic markers, it does not offer certainty about whether someone will get a disease, Pathway Genomics Director of Clinical Genetics Linda Wasserman pointed out, saying that this "is where the role of genetic counseling comes into play." By offering access to the Harvard-developed information, "we can quickly refer our customers to a source of information that is current and accurate," she said.
Financial terms of the agreement were not released.